Blog

pharmacy consulting, pharmacy consulting, independent pharmacy consulting, pharmacy brokerage services, pharmacy evaluation, pharmacy regulatory compliance

Up to date information in the field of Independent Pharmacy written by the PRS Pharmacy Consulting Experts and Pharmacists for Pharmacy Owners. Experience Matters. 

Is Your Pharmacy Still Using Windows 7?

Is your pharmacy still using windows 7? Déjà vu! It was only 5 years ago that we saw the Windows XP’s “end of life” occur.  Now, it is time for the discontinuation of Windows 7. Also note that Windows 8’s “end of life” will occur in January 2023. On January 14, 2020, Microsoft will end support for Windows 7. This means if you are currently running Windows 7 on any of your computers you will no longer receive software updates, technical support for

Read More »

USP <800> | The Independent Pharmacist’s Guide – Part 2: Does My Pharmacy Need to Comply?

If you own or manage a pharmacy, you’ve probably heard about USP <800>, the newest chapter issued by the United States Pharmacopoeial Convention. Although USP guidelines typically apply to compounding pharmacies and drug manufacturers, USP <800> guidelines apply to any facility which handles hazardous drugs; if you own or operate a pharmacy, that means YOU. However, there is a common misconception spreading through the independent pharmacy space when it comes to USP <800> compliance. In part 2 of the Independent

Read More »

USP <800> | The Independent Pharmacist’s Guide – Part 1: What Is USP <800>?

What is USP 800? What is USP 800? If you own or manage a pharmacy, you’ve probably heard about the USP 800, the newest chapter issued by the United States Pharmacopoeial Convention. Although USP guidelines typically apply to compounding pharmacies and drug manufacturers, the USP 800 guidelines apply to any facility which handles hazardous drugs; so if you own or operate a pharmacy, these rules apply to you. In this blog series, we will be conducting a brief review of

Read More »

FDA Issues Warning Letter to McKesson for Shipping ‘illegitimate’ Opiates

The Food and Drug Administration said Tuesday it has sent a warning letter to drug distributor McKessson for allegedly shipping “illegitimate” opioid products and failing to properly handle and investigate the incidents. Specifically, the FDA is accusing McKesson of failing to identify, quarantine and investigate drug shipments that had been tampered with. Some of the bad shipments were discovered at three Rite Aid pharmacies in Michigan. This is the first time the FDA has issued a warning letter under the

Read More »

The Unsung Role of the Pharmacist in Patient Health

Are people relying too much on the traditional doctor/patient interaction? We know many people end up with a risky pileup of prescribed medications. Many efforts have been made, with varied success, to correct this problem. Yet we’ve usually focused on physician behavior, when there’s another powerful lever: pharmacists. They not only provide prescription drugs and refills but also play an important role in several aspects of healthcare, which is why pharmacists are so needed. Moreover, they come into closer and more frequent physical

Read More »

Why Choose Independents Over Chains

4 Reasons to Support Independent Pharmacies We know there is a need to continue to support small independently owned businesses. Did you know that for every $100 you spend at a locally owned and operated business almost $96 goes back into the local economy? Aside from the obvious financial reasons to back support a small independent business, when we are talking about an independent community pharmacy, the stakes are even higher. The reasons why an independent is better than a

Read More »

U.S. based United Investment Healthcare Group signs agreement on trust management of Uzbekistan’s Dori-Darmon

The State Assets Management Center under the State Committee of Uzbekistan on Assistance to Privatized Enterprises and Development of Competition and the American company United Investment Healthcare Group signed an agreement on the transfer of the Dori-Darmon pharmaceutical company to trust management for a period of five years. The document sets the legal basis for the new development strategy of the national pharmaceutical company Dori-Darmon to introduce modern management methods, exclusive information technologies, as well as an effective system for

Read More »
Contact Us

P.O. BOX 852
201 Depot Street, Suite 200
Latrobe, PA 15650

Phone: 800-338-3688
Fax: 724-539-1388

CONTACT US